AIG vs CTNM · P/E 21, rev $13.73B vs $429.6M cap
American International Group Inc (AIG) versus Contineum Therapeutics, Inc. Class A Common Stock (CTNM) — a side-by-side from cached financials, not a winner call.
American International Group Inc (AIG) is a insurance - diversified company listed on US.
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is a biotechnology company listed on US.
Latest reported AIG revenue for 2026-06-30 was $13.73B. Net income was $1.71B. AIG currently screens at market cap $48.97B and trailing P/E 20.6.
Latest reported CTNM revenue for 2024-09-30 was $0. Net income was -$27.7M. CTNM currently screens at market cap $429.6M.
AIG currently screens at market cap $48.97B and trailing P/E 20.6. CTNM currently screens at market cap $429.6M.
Not investment advice. Open the AIG and CTNM stock pages for the full models.
Not investment advice.